We observed significantly more CD3-positive immune cells ( P = 0.01) in the SR of patients with high IL2RB compared to low, and a trend toward significance in the TB region with CD3 expression.
← all excerpts
Evolutionary genetic algorithm identifies <i>IL2RB</i> as a potential predictive biomarker for immune-checkpoint therapy in colorectal cancer.
1
—
—